The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab-based therapy in previously treated high grade extrapulmonary neuroendocrine carcinomas.
 
Claire Hooker
No Relationships to Disclose
 
Jennifer A. Chan
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Bayer (I); Ipsen; Lexicon; Novartis
Research Funding - Lilly (Inst); Novartis (Inst); Sanofi (Inst)
 
Rahul Raj Aggarwal
Research Funding - Gilead Sciences; Novartis; Sanofi; Zenith Epigenetics
 
Pelin Cinar
Research Funding - Newlink Genetics
 
Tom Hope
Honoraria - GE Healthcare
Research Funding - GE Healthcare
Travel, Accommodations, Expenses - GE Healthcare
 
Kanti Kolli
Stock and Other Ownership Interests - Adient Medical
Consulting or Advisory Role - Penumbra
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis
Travel, Accommodations, Expenses - Dendreon
 
Susan Calabrese
No Relationships to Disclose
 
Jennifer Ann Grabowsky
No Relationships to Disclose
 
Jenna Zhang
No Relationships to Disclose
 
Lawrence Fong
Consulting or Advisory Role - Atreca; IDEAYA Biosciences; MIODx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Nitya Prabhakar Raj
Research Funding - Novartis (Inst)
 
Emily K. Bergsland
Stock and Other Ownership Interests - More Health (I)
Consulting or Advisory Role - Ipsen; Lexicon; More Health; more health (I); Novartis
Research Funding - lexicon (Inst); Merck; Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate